- Home
- LAZ vs CRNX Comparison
LAZ vs CRNX Comparison
Compare LAZ & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAZ
- CRNX
- Stock Information
- Founded
- LAZ 1848
- CRNX 2008
- Country
- LAZ United States
- CRNX United States
- Employees
- LAZ N/A
- CRNX N/A
- Industry
- LAZ Investment Managers
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- LAZ Finance
- CRNX Health Care
- Exchange
- LAZ Nasdaq
- CRNX Nasdaq
- Market Cap
- LAZ 4.6B
- CRNX 5.2B
- IPO Year
- LAZ 2005
- CRNX 2018
- Fundamental
- Price
- LAZ $53.39
- CRNX $38.76
- Analyst Decision
- LAZ Hold
- CRNX Strong Buy
- Analyst Count
- LAZ 7
- CRNX 10
- Target Price
- LAZ $53.50
- CRNX $74.40
- AVG Volume (30 Days)
- LAZ 923.3K
- CRNX 987.7K
- Earning Date
- LAZ 01-30-2025
- CRNX 02-26-2025
- Dividend Yield
- LAZ 3.77%
- CRNX N/A
- EPS Growth
- LAZ N/A
- CRNX N/A
- EPS
- LAZ 2.55
- CRNX N/A
- Revenue
- LAZ $3,047,514,000.00
- CRNX $1,038,999.00
- Revenue This Year
- LAZ $13.52
- CRNX N/A
- Revenue Next Year
- LAZ $12.58
- CRNX $196.17
- P/E Ratio
- LAZ $20.90
- CRNX N/A
- Revenue Growth
- LAZ 25.34
- CRNX N/A
- 52 Week Low
- LAZ $35.56
- CRNX $35.51
- 52 Week High
- LAZ $61.14
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- LAZ 57.85
- CRNX 29.69
- Support Level
- LAZ $49.51
- CRNX $35.51
- Resistance Level
- LAZ $50.65
- CRNX $53.55
- Average True Range (ATR)
- LAZ 1.55
- CRNX 2.33
- MACD
- LAZ 0.43
- CRNX -1.08
- Stochastic Oscillator
- LAZ 99.87
- CRNX 18.02
About LAZ Lazard Inc.
Lazard has a storied history that can be traced back to 1848. The company's revenue is nearly equally split between financial advisory, such as acquisition and restructuring advisory, and asset management. The company's asset management business is primarily equities (over 80% of assets under management), has an international focus, and is geared toward institutional clients. By geography, the company earns approximately 60% of revenue in the Americas, 35% in EMEA, and 5% in Asia-Pacific. Lazard has offices across more than 20 countries and over 3,000 employees.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.